Abstract:Inflammasomes comprise a group of protein complexes with fundamental roles in the induction of inflammation. Upon sensing stress factors, their assembly induces the activation and release of the pro-inflammatory cytokines interleukin (IL)-1β and -18 and a lytic type of cell death, termed pyroptosis. Recently, CARD8 has joined the group of inflammasome sensors. The carboxy-terminal part of CARD8, consisting of a function-to-find-domain (FIIND) and a caspase activation and recruitment domain (CARD), resembles that of NLR family pyrin domain containing 1 (NLRP1), which is recognized as the main inflammasome sensor in human keratinocytes. The interaction with dipeptidyl peptidases 8 and 9 (DPP8/9) represents an activation checkpoint for both sensors. CARD8 and NLRP1 are activated by viral protease activity targeting their amino-terminal region. However, CARD8 also has some unique features compared to the established inflammasome sensors. Activation of CARD8 occurs independently of the inflammasome adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC), leading mainly to pyroptosis rather than the activation and secretion of pro-inflammatory cytokines. CARD8 was also shown to have anti-inflammatory and anti-apoptotic activity. It interacts with, and inhibits, several proteins involved in inflammation and cell death, such as the inflammasome sensor NLRP3, CARD-containing proteins caspase-1 and -9, nucleotide-binding oligomerization domain containing 2 (NOD2), or nuclear factor kappa B (NF-κB). Single nucleotide polymorphisms (SNPs) of CARD8, some of them occurring at high frequencies, are associated with various inflammatory diseases. The molecular mechanisms underlying the different pro- and anti-inflammatory activities of CARD8 are incompletely understood. Alternative splicing leads to the generation of multiple CARD8 protein isoforms. Although the functional properties of these isoforms are poorly characterized, there is evidence that suggests isoform-specific roles. The characterization of the functions of these isoforms, together with their cell- and disease-specific expression, might be the key to a better understanding of CARD8's different roles in inflammation and inflammatory diseases.

The CARD8 T60 variant associates with NLRP1 and negatively regulates its activation

CARD8 negatively regulates NLRP1 inflammasome activation level by interaction with NLRP1

Homotypic CARD-CARD interaction is critical for the activation of NLRP1 inflammasome

CARD8: A Novel Inflammasome Sensor with Well-Known Anti-Inflammatory and Anti-Apoptotic Activity

Inflammasome Activity is Controlled by ZBTB16-dependent SUMOylation of ASC

ABHD8 antagonizes inflammation by facilitating chaperone-mediated autophagy-mediated degradation of NLRP3

Β-Arrestin1 is Critical for the Full Activation of NLRP3 and NLRC4 Inflammasomes

The E3 Ubiquitin Ligase TRIM65 Negatively Regulates Inflammasome Activation Through Promoting Ubiquitination of NLRP3

The regulation of NLRP3 inflammasome activation by CCDC50-mediated autophagy

Novel mode of filament formation in UPA-promoted CARD8 and NLRP1 Inflammasomes

Implication of the LRR Domain in the Regulation and Activation of the NLRP3 Inflammasome

IKKα Negatively Regulates ASC-dependent Inflammasome Activation

Recent Insights into the Regulatory Networks of NLRP3 Inflammasome Activation

Tyrosine Phosphatase SHP2 Negatively Regulates NLRP3 Inflammasome Activation Via ANT1-dependent Mitochondrial Homeostasis

NLRP Inflammasomes in Health and Disease.

Negative Regulatory Mechanisms of NLRP3 Inflammasome

NLRP3 Cys126 palmitoylation by ZDHHC7 promotes inflammasome activation

SLC25A3 Negatively Regulates NLRP3 Inflammasome Activation by Restricting the Function of NLRP3

Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors

SUMO1 SUMOylates and SENP3 deSUMOylates NLRP3 to orchestrate the inflammasome activation.